Bausch Health Companies Inc (NYSE/TSX: BHC) announced on Wednesday that it is to participate in multiple upcoming investor conferences.

Sam Eldessouky, executive vice president and chief financial officer; William Woodfield, senior vice president and treasurer; and Arthur J Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the J.P. Morgan European High Yield & Leveraged Finance Conference on 9 September 2021 and the Deutsche Bank 29th Annual Leveraged Finance Conference on 4 October 2021 at 11:00 hours ET.

Joseph C Papa, chairman and chief executive officer; Sam Eldessouky, executive vice president and chief financial officer; and Arthur J Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Morgan Stanley Global Healthcare Conference 2021 on 13 September 2021 at 11:00 hours ET.

Live webcasts and audio archives of the 13 September and 4 October events will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2021.

Canada-headquartered Bausch Health Companies Inc is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.